Published in Surg Gynecol Obstet on April 01, 1982
Surgical treatment of tertiary hyperparathyroidism: the choice of procedure matters! World J Surg (2007) 2.21
Long-term follow-up of patients with tertiary hyperparathyroidism treated by resection of a single or double adenoma. Ann Surg (2002) 1.30
Operative treatment of tertiary hyperparathyroidism: a single-center experience. Ann Surg (1998) 1.07
Parathyroidectomy for hyperparathyroidism associated with renal disease. Ann R Coll Surg Engl (1995) 0.78
The changing face of parathyroid surgery. Ann R Coll Surg Engl (1984) 0.75
Parathyroid surgery in patients with renal failure. Ann Surg (1984) 0.75
Radioguided parathyroidectomy for tertiary hyperparathyroidism. J Surg Res (2015) 0.75
Graft-dependent renal hyperparathyroidism despite successful kidney transplantation. World J Surg (2008) 0.75
Racial equity in renal transplantation. The disparate impact of HLA-based allocation. JAMA (1993) 4.26
Human papillomavirus type 16 reduces the expression of microRNA-218 in cervical carcinoma cells. Oncogene (2007) 2.36
Long-term results of a controlled prospective study with transfusion of donor-specific bone marrow in 57 cadaveric renal allograft recipients. Transplantation (1991) 2.32
Renal transplantation in children with posterior urethral valves. J Urol (1991) 2.06
RS-61443--a phase I clinical trial and pilot rescue study. Transplantation (1992) 1.97
Efficacy and safety of erlotinib HCl, an epidermal growth factor receptor (HER1/EGFR) tyrosine kinase inhibitor, in patients with advanced ovarian carcinoma: results from a phase II multicenter study. Int J Gynecol Cancer (2005) 1.83
Hypertension in cyclosporine-treated renal transplant recipients is sodium dependent. Am J Med (1988) 1.60
Microchimerism and rejection in clinical transplantation. Lancet (1997) 1.53
Identification of patients with increased risk of infection with herpes simplex virus after renal transplantation. J Infect Dis (1979) 1.50
Chance factors in studies of quantitative structure-activity relationships. J Med Chem (1979) 1.47
Effect of adenine arabinoside on cytomegalovirus infections. J Infect Dis (1974) 1.39
Remission of essential hypertension after renal transplantation. N Engl J Med (1983) 1.38
Treatment of secondary hyperparathyroidism in patients with chronic renal failure by total parathyroidectomy and parathyroid autograft. Ann Surg (1981) 1.30
Conventional 3D conformal versus intensity-modulated radiotherapy for the adjuvant treatment of gynecologic malignancies: a comparative dosimetric study of dose-volume histograms. Gynecol Oncol (2003) 1.26
Training and use of surgeon's assistants. Surgery (1978) 1.25
Inhibition of angiotensin-converting enzyme in renal-transplant recipients with hypertension. N Engl J Med (1983) 1.18
Optimization of the weck-Cel collection method for quantitation of cytokines in mucosal secretions. Clin Diagn Lab Immunol (2000) 1.17
Peripheral blood chimerism in renal allograft recipients transfused with donor bone marrow. Transplantation (1994) 1.16
Renal transplantation in hypophosphatemia with vitamin D-resistant rickets. Arch Intern Med (1974) 1.16
Effect of primary and recurrent cytomegalovirus infections upon graft and patient survival after renal transplantation. Transplantation (1979) 1.15
Collection of cervical secretions does not adversely affect Pap smears taken immediately afterward. Clin Diagn Lab Immunol (1998) 1.14
Normal uterine cervix: characterization of isolated lymphocyte phenotypes and immunoglobulin secretion. Am J Reprod Immunol (1995) 1.13
RS-61443 (mycophenolate mofetil). A multicenter study for refractory kidney transplant rejection. Ann Surg (1992) 1.11
Infections caused by herpes simplex virus in the immunocompromised host: natural history and topical acyclovir therapy. J Infect Dis (1984) 1.09
Rectal immunization for induction of specific antibody in the genital tract of women. J Clin Immunol (1997) 1.08
Electron-microscope illustrations of division in Mycobacterium leprae. J Med Microbiol (1970) 1.07
Operative treatment of tertiary hyperparathyroidism: a single-center experience. Ann Surg (1998) 1.07
Cyclosporin in therapeutic doses increases renal allograft vascular resistance. Lancet (1986) 1.07
Gastrointestinal and hepatic complications affecting patients with renal allografts. Am J Surg (1975) 1.07
Cytomegalovirus infection in patients with renal transplants: potentiation by antithymocyte globulin and an incompatible graft. J Infect Dis (1980) 1.05
Cardiac responses to imipramine and pancuronium during anesthesia with halothane or enflurane. Anesthesiology (1979) 1.03
Effect of immunosuppressive therapy for renal allografts on the number of circulating sheep red blood cells rosetting cells. Transplantation (1975) 1.02
Immunobiology of human mucin 1 in a preclinical ovarian tumor model. Oncogene (2012) 1.01
Three-dimensional high dose rate intracavitary image-guided brachytherapy for the treatment of cervical cancer using a hybrid magnetic resonance imaging/computed tomography approach: feasibility and early results. Clin Oncol (R Coll Radiol) (2011) 1.01
Detection of human T cells using anti-monkey thymocyte antisera. Tissue distribution and evidence for antigenic heterogeneity. Clin Immunol Immunopathol (1977) 1.01
Use of cryopreserved donor bone marrow in cadaver kidney allograft recipients. Transplantation (1989) 1.00
One-year follow-up results of a phase I trial of mycophenolate mofetil (RS61443) in cadaveric renal transplantation. Transplant Proc (1993) 0.99
Vaginal mucosa serves as an inductive site for tolerance. J Immunol (2000) 0.99
Renal transplantation in children with posterior urethral valves revisited: a 10-year followup. J Urol (1998) 0.97
Prospective randomized trial of LLETZ versus laser ablation in patients with cervical intraepithelial neoplasia. Gynecol Oncol (1994) 0.96
Physiological and molecular effects of Apo2L/TRAIL and cisplatin in ovarian carcinoma cell lines. Cancer Lett (2003) 0.96
Epitope specificity of HLA class I alloantibodies. I. Frequency analysis of antibodies to private versus public specificities in potential transplant recipients. Hum Immunol (1994) 0.96
Vascular access for hemodialysis by bovine graft arteriovenous fistulas. Surg Gynecol Obstet (1975) 0.96
Improved survival of primary cadaveric renal allografts in blacks with quadruple immunosuppression. Transplantation (1992) 0.95
A case-matched molecular comparison of extraovarian versus primary ovarian adenocarcinoma. Cancer (1997) 0.94
Productive infection with cytomegalovirus and herpes simplex virus in renal transplant recipients: role of source of kidney. J Infect Dis (1978) 0.94
Pharmacology, tolerance, and antiviral activity of vidarabine monophosphate in humans. Antimicrob Agents Chemother (1980) 0.94
Clinical evaluation of equine antithymocyte globulin in recipients of renal allografts: Analysis of survival, renal function, rejection, histocompatibility, and complications. Ann Surg (1974) 0.92
The living donor process in kidney transplantation: influence of race and comorbidity. Transplant Proc (1997) 0.92
Effects of enalapril on erythrocytosis after renal transplantation. Ann Intern Med (1991) 0.91
Sentinel lymph node biopsy in early-stage cervical cancer: utility of intraoperative versus postoperative assessment. Gynecol Oncol (2008) 0.91
A trial of outpatient paclitaxel and carboplatin for advanced, recurrent, and histologic high-risk endometrial carcinoma: preliminary report. Semin Oncol (1997) 0.91
Fatal postoperative amiodarone pulmonary toxicity. Am J Cardiol (1988) 0.91
Aggressive therapy of infants with renal failure. Pediatr Nephrol (1987) 0.90
Chemotherapy for malignant mixed Müllerian tumors of the ovary. Gynecol Oncol (2000) 0.90
Mucocutaneous herpes simplex virus infections in immunocompromised patients. A model for evaluation of topical antiviral agents. Am J Med (1982) 0.90
Ulcerative colitis in the elderly patient. Surg Gynecol Obstet (1968) 0.90
Improved outcomes in cadaveric renal allografts with pulsatile preservation. Clin Transplant (2000) 0.89
Successful renal allografts in recipients with crossmatch-positive, dithioerythritol-treated negative sera. Race, transplant history, and HLA-DR1 phenotype. Transplantation (1989) 0.89
Renal retransplantation at the University of Alabama at Birmingham: incidence and outcome. Clin Transpl (1998) 0.89
Pharmacokinetic study of pegylated liposomal CKD-602 (S-CKD602) in patients with advanced malignancies. Clin Pharmacol Ther (2009) 0.89
Benefits of removal of native kidneys in hypertension after renal transplantation. Lancet (1985) 0.89
OKT3 first-dose reaction: association with T cell subsets and cytokine release. Kidney Int (1991) 0.88
Alterations in myocardial thallium-201 distribution in patients with chronic systemic hypertension undergoing single-photon emission computed tomography. Am J Cardiol (1988) 0.88
Risk factors affecting second renal transplant outcome, with special reference to primary allograft nephrectomy. Transplantation (1995) 0.87
Heterotopic bone formation associated with intestinal obstruction and small bowel resection. Ala J Med Sci (1983) 0.86
Surgical management of complications of steroid therapy. Ann Surg (1977) 0.86
LLETZ is an acceptable alternative to diagnostic cold-knife conization. Gynecol Oncol (1994) 0.86
Impaired lymphocyte transformation response to cytomegalovirus and phytohemagglutinin in recipients of renal transplants: association with antithymocyte globulin. J Infect Dis (1981) 0.85
Long-spacing collagen in skin biopsies from patients with lepromatous leprosy. Br J Dermatol (1975) 0.85
Erythropoiesis after withdrawal of enalapril in post-transplant erythrocytosis. Kidney Int (1994) 0.85
Analysis of 22 years experience in living-related transplantation at the University of Alabama in Birmingham. Clin Transpl (1991) 0.85
Outcome after myocardial revascularization and renal transplantation: a 25-year single-institution experience. Ann Surg (1999) 0.85
Obstruction to the renal microcirculation after temporary ischemia. J Surg Res (1971) 0.85
Tapering or discontinuing cyclosporine for financial reasons--a single-center experience. Am J Kidney Dis (1993) 0.85
Rejection of canine renal allografts by passive transfer of sensitized serum. Surgery (1968) 0.84
Gastric volvulus within hernia of foramen of Morgagni. Cause of intestinal obstruction. N Y State J Med (1966) 0.84
Gastrointestinal hemorrhage secondary to cytomegalovirus after renal transplantation. A case report and review of the problem. Am J Surg (1976) 0.84
Influence of race on renal allograft survival in the pre- and postcyclosporine era. Clin Transpl (1987) 0.84
Alternate-day prednisone therapy in recipients of renal allografts. Risk and benefits. Arch Surg (1976) 0.83
CD8+ T lymphocytes are recruited to neoplastic cervix. J Clin Immunol (1995) 0.83
Tolerance in renal transplantation after allogeneic bone marrow transplantation-6-year follow-up. Transplantation (2001) 0.83
Echocardiographic assessment of cardiac performance in patients with arteriovenous fistulas. Surg Gynecol Obstet (1978) 0.83
Associations between hepatocyte growth factor, c-Met, and basic fibroblast growth factor and survival in endometrial cancer patients. Br J Cancer (2012) 0.83
A study of the potential nephrotoxicity of heterologous anti-lymphocyte serum. Clin Exp Immunol (1970) 0.83
A rapid flow cytometry assay for HLA antibody detection using a pooled cell panel covering 14 serological crossreacting groups. Transplantation (1995) 0.82
Impact of donor/recipient size matching on outcomes in renal transplantation. Transplantation (1996) 0.82
The metabolism of myo-inositol by the human kidney. J Lab Clin Med (1979) 0.82
Infection complicating renal homotransplantation: a prospective study. Ala J Med Sci (1971) 0.82
Mechanisms of posttransplant hypertension. Am J Kidney Dis (1985) 0.81